C530-1171 Screening compound: 10-(2-fluorobenzyl)-N~8~-[3-(3-methylpiperidino)propyl]-5,5,11-trioxo-10,11-dihydro-5H-5lambda~6~-dibenzo[b,f][1,4]thiazepine-8-carboxamide

Chemical Structure Depiction of ChemDiv screening compound C530-1171
10-(2-fluorobenzyl)-N~8~-[3-(3-methylpiperidino)propyl]-5,5,11-trioxo-10,11-dihydro-5H-5lambda~6~-dibenzo[b,f][1,4]thiazepine-8-carboxamide

Available from 1 mg

Formats:

Glass Vials (4ml Glass Vials VWR #97047-678)
96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Check Price and Availability

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C530-1171

Molecular Formula

C₃₀H₃₂FN₃O₄S (C30 H32 FN3 O4 S)

Compound Name

10-(2-fluorobenzyl)-N~8~-[3-(3-methylpiperidino)propyl]-5,5,11-trioxo-10,11-dihydro-5H-5lambda~6~-dibenzo[b,f][1,4]thiazepine-8-carboxamide

IUPAC name

9-[(2-fluorophenyl)methyl]-N-[3-(3-methylpiperidin-1-yl)propyl]-2210-trioxo-2lambda6-thia-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaene-6-carboxamide

SMILES

CC1CN(CCCNC(c(cc2)cc(N(Cc(cccc3)c3F)C(c3c4cccc3)=O)c2S4(=O)=O)=O)CCC1

InChI

InChI=1S/C30H32FN3O4S/c1-21-8-6-16-33(19-21)17-7-15-32-29(35)22-13-14-28-26(18-22)34(20-23-9-2-4-11-25(23)31)30(36)24-10-3-5-12-27(24)39(28,37)38/h2-5,9-14,18,21H,6-8,15-17,19-20H2,1H3,(H,32,35)/t21-/m0/s1

InChI Key

MUFLNTOMTHKLPV-NRFANRHFSA-N

MDL Number (MFCD)

MFCD14767873

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

549.67

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

Partition Coefficient, logP

3.965

Distribution Coefficient, logD

1.393

Water Solubility, LogSw

-4.04

Polar Surface Area

72.552

Acid Dissociation Constant (pK_a)

14.37

Base Dissociation Constant (pK_b)

9.97

Number of Chiral Centers

1.00

Percent sp³ carbon bonding

33.30

C530-1171 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

CNS targets activity set (6557 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:

Cancer
Antiviral
Infections
Immune system
Cancer
Digestive system
Respiratory tract
Otorhinolaryngologic
Cancer
Digestive system
Respiratory tract
Nervous system
Eye
Cardiovascular

Targets:

Kinases
GPCR

Mechanism of action:

PPI modulators
Receptor's ligands
PPI modulators

Structure:

Mimetics

References: we are preparing a list of scientific research reports with C530-1171 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C530-1171?
Check Price and Availability of C530-1171, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.

What is the minimum amount of C530-1171 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.

Delivery options for C530-1171
ChemDiv sends parcels with Express services (UPS, WC).

1–2 days for small orders
2–4 weeks for large selections

Delivery formats for C530-1171

0.5–50 mg of dry powder sample in single glass vials, custom vials
DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C530-1171 available by request